CTNNB1 and gastric cancer: A previous study evaluated the relationship between the CTNNB1: rs1880481 polymorphism and gastric cancer; the results demonstrated that CTNNB1: rs1880481 decreased the risk of developing gastric cancer and could be used as a prognostic indicator for the disease [22], which is in accordance with our results.